Ratings by JPMorgan (Allen Gong)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Haemonetics | HAE | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/7/2026 | Establishment Labs Inc. | ESTA | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/5/2026 | TransMedics Group | TMDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/6/2026 | Alphatec Holdings | ATEC | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/1/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2026 | Glaukos Corporation | GKOS | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/25/2026 | TransMedics Group | TMDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/20/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/17/2025 | Establishment Labs Inc. | ESTA | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/6/2025 | Establishment Labs Inc. | ESTA | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/30/2025 | Glaukos Corporation | GKOS | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/30/2025 | Glaukos Corporation | GKOS | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/24/2025 | Alphatec Holdings | ATEC | New Coverage | Overweight (N/A) |
15.67 (9.48) |
-39.5% | Details | |
| 7/31/2025 | Glaukos Corporation | GKOS | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/9/2025 | TransMedics Group | TMDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/8/2025 | Establishment Labs Inc. | ESTA | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/1/2025 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2025 | TransMedics Group | TMDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/17/2024 | TransMedics Group | TMDX | Downgrade | Neutral (Overweight) |
64.26 (94.77) |
47.48% | Details | |
| 11/8/2024 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2024 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2024 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/1/2024 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/29/2024 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2024 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2023 | Glaukos Corporation | GKOS | Upgrade | Overweight (Neutral) |
81.24 (184.89) |
127.58% | Details | |
| 11/14/2023 | The Beauty Health Company | SKIN | Downgrade | Underweight (Neutral) |
3.60 (0.65) |
-81.94% | Details | |
| 11/6/2023 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/31/2023 | Establishment Labs Inc. | ESTA | New Coverage | Overweight (N/A) |
57.51 (72.67) |
26.36% | Details | |
| 8/3/2023 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/26/2023 | The Beauty Health Company | SKIN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | The Beauty Health Company | SKIN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2023 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/22/2023 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | The Beauty Health Company | SKIN | Downgrade | Neutral (Overweight) |
11.30 (0.65) |
-94.25% | Details | |
| 11/4/2022 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2022 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2022 | TransMedics Group | TMDX | Upgrade | Overweight (Neutral) |
40.38 (94.77) |
134.7% | Details | |
| 3/11/2022 | The Beauty Health Company | SKIN | New Coverage | Overweight (N/A) |
18.29 (0.65) |
-96.45% | Details | |
| 12/17/2021 | TransMedics Group | TMDX | Maintain | (Neutral) |
|
Details | ||
| 12/17/2021 | NuVasive | NUVA | Maintain | Neutral (N/A) |
|
Details |
